Recent PIRS News
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/07/2024 02:01:07 PM
- Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations • GlobeNewswire Inc. • 11/07/2024 01:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/06/2024 10:01:41 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/06/2024 10:00:43 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/17/2024 12:00:09 PM
- Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer • GlobeNewswire Inc. • 10/17/2024 11:30:00 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/15/2024 12:00:54 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/03/2024 12:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 12:00:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 10:48:13 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/08/2024 08:17:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:17:30 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/07/2024 06:16:07 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/01/2024 12:00:08 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc. • PR Newswire (US) • 07/24/2024 09:03:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/24/2024 10:40:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 10:40:14 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:01:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:14 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:37:34 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:12:19 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:19:42 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/02/2024 02:59:33 PM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM